UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD)

CUSIP: 917488108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock
Shares outstanding
3,203,885
Total 13F shares
2,559,522
Share change
-3,816
Total reported value
$219,885,103
Price per share
$85.90
Number of holders
74
Value change
-$450,030
Number of buys
32
Number of sells
39

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 917488108?
CUSIP 917488108 identifies UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
12%
381,712
$34,301,000 31 Mar 2022
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
11%
365,212
$32,818,000 31 Mar 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
7%
223,714
$20,103,000 31 Mar 2022
13F
BlackRock Finance, Inc.
13F
Company
6.7%
213,144
$19,154,000 31 Mar 2022
13F
Kevin L. Cornwell
3/4/5
Chairman, CEO, Secretary, Director
class O/S missing
188,472
$17,774,794 22 Nov 2021
VANGUARD GROUP INC
13F
Company
5.2%
165,899
$14,908,000 31 Mar 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
4.7%
149,693
$13,451,000 31 Mar 2022
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
3.6%
116,613
$10,479,000 31 Mar 2022
13F
JPMORGAN CHASE & CO
13F
Company
3.2%
101,767
$9,145,000 31 Mar 2022
13F
Russell Investments Group, Ltd.
13F
Company
2.5%
81,658
$7,336,000 31 Mar 2022
13F
Ranger Investment Management, L.P.
13F
Company
2.3%
73,110
$6,570,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
2.2%
70,584
$6,363,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.8%
58,848
$5,288,000 31 Mar 2022
13F
LOOMIS SAYLES & CO L P
13F
Company
1.8%
58,756
$5,280,000 31 Mar 2022
13F
Atle Fund Management AB
13F
Company
1.7%
56,000
$5,032,000 31 Mar 2022
13F
FRANKLIN RESOURCES INC
13F
Company
1.3%
41,777
$3,754,000 31 Mar 2022
13F
NORTHERN TRUST CORP
13F
Company
1.2%
37,040
$3,328,000 31 Mar 2022
13F
ROYCE & ASSOCIATES LP
13F
Company
0.99%
31,858
$2,863,000 31 Mar 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.91%
29,301
$2,633,000 31 Mar 2022
13F
Ancora Advisors LLC
13F
Company
0.81%
25,839
$2,322,000 31 Mar 2022
13F
Bank of New York Mellon Corp
13F
Company
0.62%
19,947
$1,793,000 31 Mar 2022
13F
ISTHMUS PARTNERS, LLC
13F
Company
0.58%
18,605
$1,672,000 31 Mar 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.46%
14,862
$1,336,000 31 Mar 2022
13F
Clean Yield Group
13F
Company
0.44%
13,959
$1,254,000 31 Mar 2022
13F
EVERETT HARRIS & CO /CA/
13F
Company
0.42%
13,425
$1,206,000 31 Mar 2022
13F
LSV ASSET MANAGEMENT
13F
Company
0.41%
13,100
$1,177,000 31 Mar 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.36%
11,658
$1,027,000 31 Mar 2022
13F
Cardinal Capital Management
13F
Company
0.33%
10,584
$951,000 31 Mar 2022
13F
SEIZERT CAPITAL PARTNERS, LLC
13F
Company
0.33%
10,430
$937,000 31 Mar 2022
13F
GLOBEFLEX CAPITAL L P
13F
Company
0.3%
9,710
$873,000 31 Mar 2022
13F
MERCER GLOBAL ADVISORS INC /ADV
13F
Company
0.3%
9,698
$871,000 31 Mar 2022
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.29%
9,345
$840,000 31 Mar 2022
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.28%
8,900
$800,000 31 Mar 2022
13F
Quadrature Capital Ltd
13F
Company
0.22%
6,914
$619,000 31 Mar 2022
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.21%
6,782
$609,000 31 Mar 2022
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.19%
5,996
$539,000 31 Mar 2022
13F
STRS OHIO
13F
Company
0.18%
5,900
$530,000 31 Mar 2022
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.18%
5,805
$521,000 31 Mar 2022
13F
Ernst G. Hoyer
3/4/5
Director
class O/S missing
5,000
$471,550 23 Nov 2021
BANK OF AMERICA CORP /DE/
13F
Company
0.16%
5,211
$468,000 31 Mar 2022
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.16%
5,137
$461,000 31 Mar 2022
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.15%
4,700
$422,000 31 Mar 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.14%
4,601
$413,000 31 Mar 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.14%
4,451
$400,000 31 Mar 2022
13F
ROYAL BANK OF CANADA
13F
Company
0.14%
4,373
$393,000 31 Mar 2022
13F
JAMES INVESTMENT RESEARCH, INC.
13F
Company
0.13%
4,270
$384,000 31 Mar 2022
13F
Annex Advisory Services, LLC
13F
Company
0.13%
4,218
$379,000 31 Mar 2022
13F
HRT FINANCIAL LP
13F
Company
0.13%
4,157
$373,000 31 Mar 2022
13F
Penobscot Investment Management Company, Inc.
13F
Company
0.12%
4,000
$359,000 31 Mar 2022
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.12%
3,688
$331,000 31 Mar 2022
13F

Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD) as of Q2 2022

As of 30 Jun 2022, UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,559,522 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, RICE HALL JAMES & ASSOCIATES, LLC, JPMORGAN CHASE & CO, HealthInvest Partners AB, and Ranger Investment Management, L.P.. This page lists 74 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
84
Q2 2022 holders
74
Holder diff
-10
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.